Twelve Capital Group was the anchor investor in Adriatic Slovenica’s note offering, providing the company with Solvency II compliant capital for a ten year period.  On 24 May 2016, the company placed EUR50 million in notes, maturing in May 2026. Twelve Capital Group acted as anchor investor and was then

Baird, an employee-owned, international financial services firm, and BR Partners, an independent investment bank in Brazil, have formed a strategic alliance for investment banking services, with an initial focus on cross-border mergers & acquisitions (M&A) between Brazil and Europe, and Brazil and the US.  Through the alliance, the two leading

Aleva Neurotherapeutics, a developer of next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson’s Disease and Essential Tremor, has raised USD 18 million in a Series C financing round.  The round was led by Greatbatch (NYSE:GB), a strategic lead investor contributing a total of USD5

Mid-market private equity firm LDC has backed the GBP22m management buyout of global ID cards business, Magicard, from listed defence and security group Ultra Electronics Holdings plc. Founded in 1992, Magicard is one of the world’s leading manufacturers of secure desktop ID card printers, software and related consumables for the

Taiyo Pacific Partners has accumulated in excess of 5 per cent in Hitachi Maxell to become the second largest shareholder in the provider of micro batteries, camera lens and LED headlamp lenses for cars.  Taiyo Pacific Partners is a pioneer of friendly engagement investing in Japan and has been proactively

NorthEdge-backed Accrol Group Holdings has revealed plans to to float on the AIM market of the London Stock Exchange. Dealings are expected to commence on AIM on 10 June 2016. Established in 1993 by the Hussain family, Accrol has grown to become a leading supplier of tissue products, supplying both

Investec Bank has arranged the long term refinancing of a portfolio of four UK projects totalling 40MW solar portfolio owned by Canadian Solar Inc (CSIQ). The long term debt was provided by Bayern LB after Investec ran competitive process for Canadian Solar.  Investec originally provided a short term bridging facility

Avista Pharma Solutions, a portfolio company of private equity firm Ampersand Capital Partners, has initiated a significant expansion and enhancement of its contract testing facility in Agawam, Massachusetts.  This facility offers Microbiology and Analytical Chemistry testing services as well as Cleanroom services (supporting environmental monitoring, qualification and certification) and has